Literature DB >> 25893926

Factors Associated with Men's Assessment of Prostate Cancer Treatment Choice.

Louie E Ross1, Daniel L Howard2,3, Janice V Bowie4,5, Roland J Thorpe4,5, Ballington L Kinlock4,5, Carol Burt4,5, Thomas A LaVeist6.   

Abstract

The objective of this study is to examine factors among a group of African American and White men in North Carolina and their assessment of prostate cancer treatment choice or belief that treatment chosen was best. A sample of men (N = 877) with a history of prostate cancer diagnosis was recruited from the North Carolina Cancer Registry during 2007-2008 and asked to participate in a telephone interview covering several measures about their initial prostate cancer treatment. Logistic regression was used to assess demographic, psychosocial, and clinical factors on whether they felt that they had chosen the best treatment for the disease. Respondents were majority White (52.7 %), married (75.9 %), and had surgery (67.9 %) as their initial treatment. At the bivariate level, factors associated with the belief that the treatment chosen was best were as follows: White race/ethnicity, higher levels of education, a more recent treatment date, having health insurance coverage, type of treatment received, higher levels of bother from side effects, greater contentment with their quality of life, and doctor discussions of the various treatment options. Similarly, the multivariate analysis showed increased odds of belief that the treatment chosen was the best among demographic (i.e., race/ethnicity, level of education, and health insurance coverage) as well as psychosocial and clinical variables (i.e., greater bother from side effects, greater contentment with their quality of life, and initial treatment received). Results suggest that demographic, psychosocial, and clinical factors play an important role for men in assessing their treatment choices for prostate cancer.

Entities:  

Keywords:  Disparity; Prostate cancer; Quality of life; Race; Survivorship; Treatment choice

Mesh:

Year:  2016        PMID: 25893926      PMCID: PMC6438370          DOI: 10.1007/s13187-015-0837-9

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  21 in total

1.  Treatment decision-making strategies and influences in patients with localized prostate carcinoma.

Authors:  Clement K Gwede; Julio Pow-Sang; John Seigne; Randy Heysek; Mohamed Helal; Kristin Shade; Alan Cantor; Paul B Jacobsen
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

2.  Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.

Authors:  Donna L Berry; Qian Wang; Barbara Halpenny; Fangxin Hong
Journal:  Patient Educ Couns       Date:  2012-05-17

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Treatment decision making in prostate cancer: patients' participation in complex decisions.

Authors:  Maarten Fischer; Adriaan Visser; Bert Voerman; Bert Garssen; George van Andel; Jozien Bensing
Journal:  Patient Educ Couns       Date:  2006-09-11

5.  Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.

Authors:  Sara E Wagner; Bettina F Drake; Keith Elder; James R Hébert
Journal:  Cancer Causes Control       Date:  2011-08-30       Impact factor: 2.506

6.  Early prostate cancer--which treatment do men prefer and why?

Authors:  Carmel N Anandadas; Noel W Clarke; Susan E Davidson; Patrick H O'Reilly; John P Logue; Lynne Gilmore; Ric Swindell; Richard J Brough; Guy D Wemyss-Holden; Maurice W Lau; Pradip M Javle; Vijay A C Ramani; James P Wylie; Gerald N Collins; Stephen Brown; Richard A Cowan
Journal:  BJU Int       Date:  2010-11-17       Impact factor: 5.588

7.  Cancer survivors--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-03-11       Impact factor: 17.586

8.  Treatment decision regret and related factors following radical prostatectomy.

Authors:  Yu-Hua Lin
Journal:  Cancer Nurs       Date:  2011 Sep-Oct       Impact factor: 2.592

9.  Decisional regret and quality of life after participating in medical decision-making for early-stage prostate cancer.

Authors:  B J Davison; S L Goldenberg
Journal:  BJU Int       Date:  2003-01       Impact factor: 5.588

10.  Determinants of treatment regret in low-income, uninsured men with prostate cancer.

Authors:  Jim C Hu; Lorna Kwan; Tracey L Krupski; Jennifer T Anger; Sally L Maliski; Sarah Connor; Mark S Litwin
Journal:  Urology       Date:  2008-03-03       Impact factor: 2.649

View more
  4 in total

1.  Prevalence and Correlates of Major Depressive Symptoms among Black Men with Prostate Cancer.

Authors:  Ballington L Kinlock; Lauren J Parker; Daniel L Howard; Janice V Bowie; Thomas A LaVeist; Roland J Thorpe
Journal:  Ethn Dis       Date:  2017-12-07       Impact factor: 1.847

2.  Prostate Cancer Patients' Understanding of the Gleason Scoring System: Implications for Shared Decision-Making.

Authors:  Erin K Tagai; Suzanne M Miller; Alexander Kutikov; Michael A Diefenbach; Ronak A Gor; Tahseen Al-Saleem; David Y T Chen; Sara Fleszar; Gem Roy
Journal:  J Cancer Educ       Date:  2019-06       Impact factor: 2.037

3.  Religious Coping and Types and Sources of Information Used in Making Prostate Cancer Treatment Decisions.

Authors:  Janice V Bowie; Caryn N Bell; Altovise Ewing; Ballington Kinlock; Ashley Ezema; Roland J Thorpe; Thomas A LaVeist
Journal:  Am J Mens Health       Date:  2017-02-13

4.  Health Literacy Is an Independent Predictor of Cancer Patients' Hospitalizations.

Authors:  Laura A Cartwright; Levent Dumenci; J Brian Cassel; Maria D Thomson; Robin K Matsuyama
Journal:  Health Lit Res Pract       Date:  2017-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.